Product Overview

Jiomist-OX Nasal Spray is a fixed-dose combination nasal formulation containing Fluticasone Furoate and Oxymetazoline Hydrochloride.

Each metered spray delivers Fluticasone Furoate 27.5 mcg and Oxymetazoline Hydrochloride 50 mcg. The product is supplied as a 7 g nasal spray with 70 metered doses.

The combination is designed for the management of allergic rhinitis associated with nasal congestion. Fluticasone Furoate is an intranasal corticosteroid that helps control inflammation associated with allergic rhinitis, while Oxymetazoline is a topical nasal decongestant that helps reduce nasal obstruction through vasoconstriction.

This combination provides a differentiated nasal dosage form for pharmaceutical portfolios focused on allergy, ENT and nasal-care segments.

What Is Jiomist-OX Nasal Spray Used For?

Jiomist-OX Nasal Spray is used for the management of allergic rhinitis, particularly when nasal congestion is a significant symptom.

Allergic rhinitis can cause symptoms such as nasal congestion, runny nose, sneezing and other allergy-related nasal symptoms. Fluticasone Furoate helps address the inflammatory component of allergic rhinitis, while Oxymetazoline provides decongestant action to help relieve nasal obstruction. Clinical studies of this fixed-dose combination have evaluated its use in adults with allergic rhinitis and moderate-to-severe nasal congestion.

The product should be used according to the approved prescribing information and healthcare professional guidance.

Product Details

Key Product Highlights

• Fixed-dose combination nasal spray
• Contains Fluticasone Furoate + Oxymetazoline Hydrochloride
• 27.5 mcg + 50 mcg per metered spray
• 70 metered doses
• 7 g net content
• Used in allergic rhinitis with nasal congestion
• Combines intranasal corticosteroid and nasal decongestant components
• Specialized ENT and allergy-care formulation
• Suitable for focused pharmaceutical product portfolios

How the Combination Works

Fluticasone Furoate

Fluticasone Furoate is an intranasal corticosteroid with anti-inflammatory activity. It helps reduce inflammatory processes associated with allergic rhinitis and supports control of nasal allergy symptoms.

Oxymetazoline Hydrochloride

Oxymetazoline is a topical nasal decongestant that acts on adrenergic receptors in the nasal blood vessels, producing vasoconstriction and helping reduce nasal mucosal swelling and congestion.

Combination Advantage

The combination provides a dual-action approach: Fluticasone Furoate targets the inflammatory component of allergic rhinitis, while Oxymetazoline provides rapid decongestant action for nasal obstruction.

B2B Pharma Portfolio Opportunity

Allergy and ENT products form an important part of many pharmaceutical portfolios. A specialized combination nasal spray can provide an additional dosage-form option for businesses serving the allergy and respiratory-care segments.

Jiomist-OX Nasal Spray can be considered by PCD pharma franchise partners, pharmaceutical distributors, stockists, super stockists and pharma marketers looking to expand their product portfolio with a combination nasal formulation for allergic rhinitis and nasal congestion.

Its dual-ingredient formulation and 70-dose presentation make it a differentiated option within an ENT-focused pharmaceutical range.

Why Consider Jiomist-OX for Your Pharma Portfolio?

Jiomist-OX offers:

• A combination of two established nasal-care ingredients
• Dual therapeutic approach to allergic rhinitis with congestion
• Specialized nasal spray dosage form
• 27.5 mcg Fluticasone Furoate + 50 mcg Oxymetazoline HCl per spray
• 70 metered-dose presentation
• 7 g pack
• Relevance to allergy and ENT product portfolios
• Suitable for B2B pharmaceutical distribution and marketing channels

Packing Information

Net Content: 7 g

Metered Doses: 70

Dosage Form: Nasal Spray

The final commercial packing configuration and approved product specifications should be confirmed from the latest product documentation before ordering or regulatory publication.

Ideal B2B Buyers

Jiomist-OX Nasal Spray may be relevant for:

• PCD Pharma Franchise Partners
• Pharma Distributors
• Stockists & Super Stockists
• Pharma Marketing Companies
• ENT Product Portfolio Owners
• Allergy & Respiratory Product Suppliers
• Institutional Pharmaceutical Buyers
• Export / International Pharma Buyers, subject to applicable regulatory requirements

Business Enquiry

Looking to add a Fluticasone Furoate + Oxymetazoline Nasal Spray to your pharmaceutical portfolio?

Connect with Farlex Pharmaceuticals Pvt. Ltd. for product availability, commercial details, business partnership opportunities and applicable product-range information.

Enquire Now for Product & Business Details.